<DOC>
	<DOCNO>NCT02139033</DOCNO>
	<brief_summary>This study evaluate efficacy Retaine™ ophthalmic emulsion treat sign symptom dry eye syndrome .</brief_summary>
	<brief_title>A Phase 4 Study Investigating Efficacy Retaine™ Managing Signs Symptoms Associated With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Be least 18 year age ; Provide write informed consent ; Have report history dry eye ; Have history use desire use eye drop ; Have clinically significant eye finding require therapeutic treatment , and/or opinion investigator may interfere study parameter ; Have wear contact lenses within 7 day Visit 1 anticipate use contact lens study ; Have previously laserassisted situ keratomileusis ( LASIK ) surgery within last 12 month ; Have use Restasis® within 30 day Visit 1 ; Be woman pregnant , nurse planning pregnancy ; Be unwilling submit urine pregnancy test childbearing potential ; Have know allergy and/or sensitivity test article component ; Have condition situation investigator feel may put subject significant risk , may confound study result , may interfere significantly subject 's participation study ; Be currently enrol investigational drug device study use investigational drug device within 30 day Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Dry Eye , Dry Eye Syndrome , Retaine , KCS , Keratoconjunctivitis sicca</keyword>
</DOC>